Anti-Cd123 Targeted Therapy With Talacotuzumab In Advanced Mds And Aml After Failing Hypomethylating Agents - Final Results Of The Samba Trial

BLOOD(2018)

引用 18|浏览5
暂无评分
摘要
Introduction
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要